Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
GILD
NVS
Add up to 3 more stocks
GILD
Gilead Sciences, Inc.
-1.87%
$144.74-2.76Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$179.47B
52W Range
$109.66 - $157.29
NVS
Novartis AG
-0.04%
$141.00-0.05Delayed quote: Oct 2, 2026, 4:00 PM EDT
Market Cap
$268.00B
52W Range
$121.57 - $170.46
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | 21.27 |
| Forward P/E | N/A | 16.02 |
| PEG Ratio | N/A | 1.38 |
| P/B Ratio | 15.17 | 6.45 |
| P/S Ratio | 5.89 | 4.82 |
| P/FCF Ratio | 13.87 | 16.94 |
| EV/EBITDA | N/A | 13.85 |
| Profitabilitytrailing twelve months | ||
| Gross Margin | 79.6% | 74.4% |
| Operating Margin | 39.7% | 30.5% |
| Net Margin | -10.6% | 22.9% |
| ROE | -27.4% | 30.7% |
| ROA | -6.6% | 10.5% |
| ROIC | -3.7% | 13.9% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 1.27 | 0.86 |
| Quick Ratio | 1.09 | 0.67 |
| Debt/Equity | 2.22 | 1.18 |
| Interest Coverage | 11.43 | 14.38 |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | 2.3% | 3.4% |
| Payout Ratio | N/A | 71.5% |
| Yrs of Dividend Growth | 10 | 1 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.